SPRY - ARS Pharmaceuticals, Inc. -  [ ]

Ticker Details
ARS Pharmaceuticals, Inc.
IPO Date: December 4, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $889.64M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.29 | 2.95%
Avg Daily Range (30 D): $0.32 | 3.04%
Avg Daily Range (90 D): $0.33 | 3.42%
Institutional Daily Volume
Avg Daily Volume: 1.04M
Avg Daily Volume (30 D): 1.29M
Avg Daily Volume (90 D): 1.55M
Trade Size
Avg Trade Size (Sh.): 90
Avg Trade Size (Sh.) (30 D): 80
Avg Trade Size (Sh.) (90 D): 86
Institutional Trades
Total Institutional Trades: 789
Avg Institutional Trade: $1.62M
Avg Institutional Trade (30 D): $1.2M
Avg Institutional Trade (90 D): $1.46M
Avg Institutional Trade Volume: .14M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.83M
Avg Closing Trade (30 D): $1.38M
Avg Closing Trade (90 D): $1.65M
Avg Closing Volume: 160.39K
 
News
Nov 10, 2025 @ 11:00 AM
ARS Pharmaceuticals Reports Third Quarter 2025 Fin...
Source: Ars Pharmaceuticals
Aug 13, 2025 @ 7:04 PM
ARS Pharma Sales Jump 3,040% in Q2
Source: Jesterai
Jan 6, 2025 @ 1:00 PM
ARS Pharmaceuticals Files for Approval of neffyÂÂ...
Source: N/A
Dec 13, 2024 @ 9:58 PM
ARSファーマシューã...
Source: N/A
Dec 13, 2024 @ 9:58 PM
ARS Pharmaceuticals 宣布在中å›Â...
Source: Ars Pharmaceuticals, Inc.
Financials
  TTM Q3 2025 Q2 2025
Basic EPS $-.81 $-.52
Diluted EPS $-.81 $-.52
Revenue $142.77M $32.5M
Gross Profit
Net Income / Loss $-80.04M $-51.15M
Operating Income / Loss $-90.79M $-53.19M
Cost of Revenue
Net Cash Flow $19.9M
PE Ratio